
Shidapa 5mg Tablet
Marketer
Shine Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Shidapa 5mg Tablet
Metformin 5mg tablets are indicated, either independently or as part of a multi-drug regimen, for managing type 2 diabetes. This medication regulates elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to cardiovascular health. Metformin 5mg can be administered with or without food, at any point in the day, but consistent daily timing is recommended. Dosage is determined by your physician and should not be altered without their guidance; discontinuation may lead to hyperglycemia and serious consequences such as renal impairment or vision loss. This medication forms part of a comprehensive treatment plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Commonly reported adverse effects include vaginal yeast infections, upper respiratory tract inflammation, and urinary tract infections. Dehydration may occur; increased fluid intake is advised. Practicing good hygiene can help minimize the likelihood of genital infections. Prior to commencing treatment, disclose any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should consult their physician before use. Limit alcohol consumption during treatment to reduce the possibility of side effects. Regular blood glucose monitoring is crucial while using this medicine.
Primary Ingredients of Shidapa 5mg Tablet
There is no text provided to rephrase.
Uses of Shidapa 5mg Tablet
Managing type 2 diabetes
Major Benefits of Shidapa 5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Shidapa 5mg Tablets can be administered with or without food, however, consistent daily timing is recommended.
Common Side effects of Shidapa 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Shidapa 5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 5mg Shidapa tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
How Shidapa 5mg Tablet works:
Shidapa 5mg tablets manage high blood sugar by facilitating increased urinary sugar excretion.
SAFETY ADVICE
AlcoholUNSAFE
Combining Shidapa 5mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Shidapa 5mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Shidapa 5mg Tablets are likely incompatible. Available data in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Individuals with kidney impairment should likely refrain from using Shidapa 5mg tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
For individuals with hepatic impairment, Shidapa 5mg tablets are considered safe for administration. No modification to the Shidapa 5mg tablet dosage is necessary.
What if you forget to take Shidapa 5mg Tablet :
Should you forget to take your Shidapa 5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Shidapa 5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
